P70434
Gene name |
Irf7 |
Protein name |
Interferon regulatory factor 7 |
Names |
IRF-7 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:54123 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
1-146 (N-terminal DNA-binding domain); 468-503 (Signal response domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Sathish N et al. (2011) "Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45", The Journal of biological chemistry, 286, 746-56
- Remesh SG et al. (2015) "Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain", The Journal of biological chemistry, 290, 27779-90
- Brass AL et al. (1999) "Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers", The EMBO journal, 18, 977-91
- Ning S et al. (2011) "IRF7: activation, regulation, modification and function", Genes and immunity, 12, 399-414
- Lin R et al. (1999) "Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains", Molecular and cellular biology, 19, 2465-74
Autoinhibited structure

Activated structure

2 structures for P70434
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
3QU3 | X-ray | 130 A | A/B/C | 1-134 | PDB |
AF-P70434-F1 | Predicted | AlphaFoldDB |
16 variants for P70434
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs232821153 | 53 | E>A | No | Ensembl | |
rs264525177 | 123 | E>A | No | Ensembl | |
rs249676166 | 126 | R>P | No | Ensembl | |
rs234530479 | 135 | A>G | No | Ensembl | |
rs222916805 | 137 | E>G | No | Ensembl | |
rs251278696 | 143 | S>T | No | Ensembl | |
rs233664403 | 146 | N>S | No | Ensembl | |
rs244197735 | 199 | P>S | No | Ensembl | |
rs262079661 | 239 | S>N | No | Ensembl | |
rs241107012 | 258 | V>M | No | Ensembl | |
rs212256864 | 342 | G>D | No | Ensembl | |
rs250283778 | 345 | T>N | No | Ensembl | |
rs235447420 | 354 | R>C | No | Ensembl | |
rs217166688 | 354 | R>H | No | Ensembl | |
rs36290645 | 401 | T>S | No | Ensembl | |
rs36944424 | 446 | I>L | No | Ensembl |
No associated diseases with P70434
4 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
5 GO annotations of molecular function
Name | Definition |
---|---|
cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by some RNA polymerase. The proximal promoter is in cis with and relatively close to the core promoter. |
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
sequence-specific double-stranded DNA binding | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. |
16 GO annotations of biological process
Name | Definition |
---|---|
defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
immunoglobulin mediated immune response | An immune response mediated by immunoglobulins, whether cell-bound or in solution. |
positive regulation of interferon-alpha production | Any process that activates or increases the frequency, rate, or extent of interferon-alpha production. |
positive regulation of interferon-beta production | Any process that activates or increases the frequency, rate, or extent of interferon-beta production. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of transcription, DNA-templated | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of type I interferon production | Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
positive regulation of type I interferon-mediated signaling pathway | Any process that increases the rate, frequency or extent of a type I interferon-mediated signaling pathway. |
regulation of adaptive immune response | Any process that modulates the frequency, rate, or extent of an adaptive immune response. |
regulation of gene expression | Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
regulation of innate immune response | Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection. |
regulation of MyD88-dependent toll-like receptor signaling pathway | Any process that modulates the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway. |
regulation of MyD88-independent toll-like receptor signaling pathway | Any process that modulates the frequency, rate, or extent of MyD88-independent toll-like receptor signaling pathway. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
type I interferon signaling pathway | The series of molecular signals initiated by type I interferon binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
7 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q90643 | IRF3 | Interferon regulatory factor 3 | Gallus gallus (Chicken) | SS |
Q92985 | IRF7 | Interferon regulatory factor 7 | Homo sapiens (Human) | EV |
Q61179 | Irf9 | Interferon regulatory factor 9 | Mus musculus (Mouse) | PR |
P56477 | Irf5 | Interferon regulatory factor 5 | Mus musculus (Mouse) | SS |
Q64287 | Irf4 | Interferon regulatory factor 4 | Mus musculus (Mouse) | EV |
P70671 | Irf3 | Interferon regulatory factor 3 | Mus musculus (Mouse) | SS |
P23611 | Irf8 | Interferon regulatory factor 8 | Mus musculus (Mouse) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MAEVRGVQRV | LFGDWLLGEV | SSGQYEGLQW | LNEARTVFRV | PWKHFGRRDL | DEEDAQIFKA |
70 | 80 | 90 | 100 | 110 | 120 |
WAVARGRWPP | SGVNLPPPEA | EAAERRERRG | WKTNFRCALH | STGRFILRQD | NSGDPVDPHK |
130 | 140 | 150 | 160 | 170 | 180 |
VYELSRELGS | TVGPATENRE | EVSLSNALPT | QGVSPGSFLA | RENAGLQTPS | PLLSSDAGDL |
190 | 200 | 210 | 220 | 230 | 240 |
LLQVLQYSHI | LESESGADPV | PPQAPGQEQD | RVYEEPYAAW | QVEAVPSPRP | QQPALTERSL |
250 | 260 | 270 | 280 | 290 | 300 |
GFLDVTIMYK | GRTVLQAVVG | HPRCVFLYSP | MAPAVRTSEP | QPVIFPSPAE | LPDQKQLHYT |
310 | 320 | 330 | 340 | 350 | 360 |
ETLLQHVSPG | LQLELRGPSL | WALRMGKCKV | YWEVGSPMGT | TGPSTPPQLL | ERNRHTPIFD |
370 | 380 | 390 | 400 | 410 | 420 |
FSTFFRELEE | FRARRRQGSP | HYTIYLGFGQ | DLSAGRPKEK | TLILVKLEPW | VCKAYLEGVQ |
430 | 440 | 450 | |||
REGVSSLDSS | SLGLCLSSTN | SLYEDIEHFL | MDLGQWP |